Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by B Sherrill
Q-TWiST Analysis Comparing Ipilimumab/Dacarbazine vs Placebo/Dacarbazine for Patients With Stage III/IV Melanoma
British Journal of Cancer
Cancer Research
Oncology
Q-TWiST Analysis of Lapatinib Combined With Capecitabine for the Treatment of Metastatic Breast Cancer
British Journal of Cancer
Cancer Research
Oncology
Related publications
Sequential Administration of Varying Doses of Dacarbazine and Fotemustine in Advanced Malignant Melanoma
British Journal of Cancer
Cancer Research
Oncology
MA05.02 PACIFIC Subgroup Analysis: Pneumonitis in Stage III, Unresectable NSCLC Patients Treated With Durvalumab vs. Placebo After CRT
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Fatal Myocarditis and Rhabdomyositis in a Patient With Stage IV Melanoma Treated With Combined Ipilimumab and Nivolumab
Current Oncology
Oncology
Eribulin Versus Dacarbazine in Patients With Leiomyosarcoma: Subgroup Analysis From a Phase 3, Open-Label, Randomised Study
British Journal of Cancer
Cancer Research
Oncology
Extended Dose Ipilimumab With a Peptide Vaccine: Immune Correlates Associated With Clinical Benefit in Patients With Resected High-Risk Stage IIIc/IV Melanoma
Clinical Cancer Research
Cancer Research
Oncology
Long-Term Follow Up of Patients With Human Immunodeficiency Virus Infection and Advanced Stage Hodgkin's Lymphoma Treated With Doxorubicin, Bleomycin, Vinblastine and Dacarbazine
Haematologica
Hematology
PCN20 Comparative Efficacy and Economic Evaluation of Dacarbazine and Temozolomide in Treatment of Malignant Melanoma in Iran
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
A Phase III Study (CheckMate 238) of Adjuvant Immunotherapy With Nivolumab (NIVO) Versus Ipilimumab (IPI) After Complete Resection of Stage IIIb/c or Stage IV Melanoma (MEL) in Patients (Pts) at High Risk for Recurrence
Journal for ImmunoTherapy of Cancer
Oncology
Molecular Medicine
Pharmacology
Cancer Research
Allergy
Immunology
Bevacizumab Plus Ipilimumab in Patients With Metastatic Melanoma
Cancer immunology research
Cancer Research
Immunology
